Respondents
The prescription at the end of the consultation
The Art of Doctoring November 9, 2020
Respondents
Photo by pina messina on Unsplash
Why your doctor examines you
The Art of Doctoring October 27, 2020
In the second question in our two-minute question series Dr. Moyez Jiwa, host of the Health Design podcast asks if the clinical examination is a crucial part of the experience when visiting a doctor.
The respondents have all been featured in our podcasts. You an hear the longer conversations here:
Photo by Hush Naidoo on Unsplash
Could the greatest hope for primary care be in a laboratory?
The Art of Doctoring May 14, 2020
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by inflammation and damage of the joints affecting about 0.5% of the general population. Early treatment in RA is important as it can prevent disease progression and irreversible damage of the joints. Despite the high diagnostic value of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor (RF), there is a strong demand for novel serological biomarkers to further improve the diagnosis of this abundant disease. During the last decades, several autoantigens have been described in RA including Ra33 (hnRNP A2), fibrinogen, fibronectin, alpha-enolase, type II collagen, immunoglobulin binding protein (BiP), annexins and viral citrullinated peptide (VCP) derived from Epstein Barr Virus-encoded protein (EBNA-2). More recent discoveries include antibodies to carbamylated antigens (anti-CarP), to peptidyl arginine deiminase type 4 (PAD4), to BRAF (v raf murine sarcoma viral oncogene homologue B1) and to 14 autoantigens identified by phage display technology. This review provides a current overview of novel biomarkers for RA and discusses their future potential to improve the diagnosis of the disease.
Trouw and Mahler
See also my podcast with Sam Mazin
Photo by Jesus Kiteque on Unsplash
